K1
Generic Name: granisetron
Pill imprint K1 has been identified as Kytril 1 MG.
Kytril is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative; nausea/vomiting, radiation induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy.
Kytril 1 MG is not subject to the Controlled Substances Act.
See also related documents.
Kytril Images
- Generic Name:
- granisetron
- Imprint:
-
K1
- Strength:
- 1 MG
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Three-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose 2208 (15000 mPa.s)
lactose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0241
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4139 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More KYTRIL resources
- Kytril
- Kytril (Wolters Kluwer)
- Kytril Solution (Wolters Kluwer)
- Kytril Tablets (Wolters Kluwer)
- Kytril (Cerner Multum)
- Kytril (Micromedex) - Includes Dosage Information
- Kytril (AHFS DI)
- Kytril (FDA)


